Digitoxin
(Synonyms: 洋地黄毒苷) 目录号 : GC34013A cardiac glycoside with diverse biological activities
Cas No.:71-63-6
Sample solution is provided at 25 µL, 10mM.
Digitoxin is a cardiac glycoside that has been found in Digitalis and has diverse biological activities.1,2,3,4,5 It inhibits human recombinant α1β1, α2β2, and α3β1 subunit-containing Na+/K+-ATPases with Ki values of 250, 63, and 136 nM, respectively.1 Digitoxin inhibits the human-ether-a-go-go (hERG) potassium channel, also known as Kv11.1, in HEK293 cells expressing hERG (IC50 = 11.1 nM).2 It enhances developed tension and contractile force in electrically stimulated isolated guinea pig left atrial muscle when used at concentrations of 0.2 and 0.4 ?M, respectively.3 Dietary administration of digitoxin (~1 mg/kg per day) attenuates congestive heart failure and reduces myocardial hypertrophy in a rat model of myocardial infarction induced by coronary artery ligation.4 Digitoxin is also cytotoxic to a panel of 10 human cancer cell lines, including myeloma, lymphoma, and leukemia cancer cells, with IC50 values ranging from 12 to 76 nM.5 Formulations containing digitoxin have previously been used in the treatment of congestive heart failure and cardiac arrhythmias.
1.Katz, A., Lifshitz, Y., Bab-Dinitz, E., et al.Selectivity of digitalis glycosides for isoforms of human Na,K-ATPaseJ. Biol. Chem.285(25)19582-19592(2010) 2.Wang, L., Wible, B.A., Wan, X., et al.Cardiac glycosides as novel inhibitors of human ether-a-go-go-related gene channel traffickingJ. Pharmacol. Exp. Ther.320(2)525-534(2007) 3.Temma, K., Akera, T., and Brody, T.M.Inotropic effects of digitoxin in solated guines-pig heart under conditions which alter contractionEur. J. Pharm.76(4)361-370(1981) 4.Picollo, C.T., dos Santos, A.A., Antonio, E.L., et al.Digitoxin attenuates heart failure, reduces myocardial hypertrophy, and preserves the calcium-binding proteins in infarcted ratsJ. Cardiovasc. Pharmacol. Ther.25(3)265-272(2019) 5.Johansson, S., Lindholm, P., Gullbo, J., et al.Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cellsAnticancer Drugs12(5)475-483(2001)
Cas No. | 71-63-6 | SDF | |
别名 | 洋地黄毒苷 | ||
Canonical SMILES | C[C@H]1O[C@](O[C@@H]2[C@@H](C)O[C@](O[C@H]3[C@@H](O)C[C@@](O[C@@H]4C[C@](CC[C@]5([H])[C@]6([H])CC[C@@]7(C)[C@]5(O)CC[C@@H]7C(CO8)=CC8=O)([H])[C@]6(C)CC4)([H])O[C@@H]3C)([H])C[C@@H]2O)([H])C[C@H](O)[C@@H]1O | ||
分子式 | C41H64O13 | 分子量 | 764.94 |
溶解度 | DMSO : ≥ 100 mg/mL (130.73 mM) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 1.3073 mL | 6.5365 mL | 13.0729 mL |
5 mM | 0.2615 mL | 1.3073 mL | 2.6146 mL |
10 mM | 0.1307 mL | 0.6536 mL | 1.3073 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet